A multiple targeting rapamycin and SS31 conjugate enhances ischemic stroke therapy
In vivo delivery of RS31 is an effective therapeutic strategy for I/R injury, providing a general framework for developing multi-targeted drugs against inflammatory diseases and excessive ROS production.
Authors
- Bohong Yu
- Xin Li (ORCID: https://orcid.org/0000-0002-4664-0244)
- Mingyuan Zhong
- Andi Sun
- Yongjun Wang (ORCID: https://orcid.org/0000-0002-2801-4573)
- Weijia Huang (ORCID: https://orcid.org/0000-0001-6531-0059)
- Hongzhuo Liu (ORCID: https://orcid.org/0000-0001-5825-0721)
- Kai Jin (ORCID: https://orcid.org/0000-0003-2489-2173)
Institutions
- Shenyang Pharmaceutical University (CN)
- Jinzhou Medical University (CN)
Publication Details
- Journal
- Expert Opinion on Drug Delivery
- Published
- 2024-12-12
- DOI
- https://doi.org/10.1080/17425247.2024.2440094
- Citations
- 2
- Primary Topic
- Natural Compounds in Disease Treatment
- Type
- article
- Field-Weighted Citation Impact
- 1.43